Philip Morris International Other Receivables increased by 20.5% to $1.24B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 39.7%, from $886.00M to $1.24B. Over 3 years (FY 2022 to FY 2025), Other Receivables shows an upward trend with a 11.0% CAGR.
Significant fluctuations may indicate one-time events or changes in non-operating business activities.
This category includes miscellaneous claims for cash that are not derived from standard trade sales of pharmaceutical pr...
Varies widely based on the complexity of a company's tax structure and collaborative R&D agreements.
other_receivables| Q4 '22 | Q4 '23 | Q4 '24 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|
| Value | $906.00M | $930.00M | $886.00M | $895.00M | $1.03B | $1.24B |
| QoQ Change | — | +2.6% | -4.7% | +1.0% | +14.7% | +20.5% |
| YoY Change | — | +2.6% | -4.7% | — | — | +39.7% |
We use cookies for analytics. See our Privacy and Cookie Policy.